BrainScope Company, Inc.

BrainScope Receives Innovative Technology Contract from Vizient for Its Novel Head Injury Triage Medical Device

Retrieved on: 
Tuesday, August 9, 2022
Nursing, Medical Supplies, Biotechnology, FDA, Health, Neurology, Other Science, Medical Devices, Research, Hospitals, Science, FDA, Emergency department, CT scan, Attending physician, Biomarker, Patient safety, Injury, Algorithm, ACEP, Brain, Cancer, BrainScope Company, Inc., CT, Hospital, Health, The Queen's Award for Enterprise: Innovation (Technology) (2011), American College, Patient, Review, Disability, Academic health science centre, Intracranial hemorrhage, Radiation, Fellow of the American College of Emergency Physicians, Emergency, Concussion, Artificial intelligence, Technology, Physician, Head, Head injury, Clinical Information Technology Program Office, Medical device, Medical imaging, Vizient, Inc.

Innovative Technology contracts are recommended after review and interaction with products submitted through Vizients Innovative Technology Program.

Key Points: 
  • Innovative Technology contracts are recommended after review and interaction with products submitted through Vizients Innovative Technology Program.
  • We are so proud to have received the Innovative Technology contract from Vizient said Susan Hertzberg, Chief Executive Officer of BrainScope.
  • Health care experts on Vizient member councils evaluated BrainScope as part of our Innovative Technology Program, said Kelly Flaharty, senior director of contract process for Vizient.
  • Vizient may award a contract to products deemed worthy of the Innovative Technology designation outside of the competitive bid cycle.

Healthcare Nanotechnology Global Market Research Report 2022 - ResearchAndMarkets.com

Retrieved on: 
Friday, July 29, 2022
Health, Nanotechnology, Pharmaceutical, Technology, Health Technology, Acquisition, S.A, Carbon, Health care, Mallinckrodt, Conditional sentence, UCB (company), Abbott Laboratories, Tissue, Johnson & Johnson, Health, Johnson, Asia-Pacific, Partnership, Solution, COVID-19, Pfizer, Celgene, Leadiant Biosciences, Cancer, Organization, Biotechnology, Infection, Nanotechnology, Science, Patient, BrainScope Company, Inc., Prevalence, Therapy, Growth, GE Healthcare, UCB, Renewable energy, Pharmaceutical industry, Medical device

The "Healthcare Nanotechnology Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Healthcare Nanotechnology Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.
  • The healthcare nanotechnology market consists of sales of healthcare nanotechnology solutions by entities (organizations, sole traders, and partnerships) which refers to the area of science that combines nanotechnology with drugs or diagnostic molecules to improve the performance of specific cells or tissues.
  • The countries covered in the Healthcare Nanotechnology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
  • Global Healthcare Nanotechnology Forecast Market, 2021-2026F, 2031F, $ Billion

Better Choice to Join Russell Microcap® Index

Retrieved on: 
Tuesday, June 21, 2022
Dog, Industry, Parent, Company, Knowledge, FTSE Russell, Growth, Russell, Health, Halo, Food, BrainScope Company, Inc., NYSE, Cat, GLOBE, Industrial design

NEW YORK, June 21, 2022 (GLOBE NEWSWIRE) -- Better Choice Company Inc. (NYSE: BTTR) (the Company or Better Choice), a pet health and wellness company, today announced that the Company is anticipated to join the Russell Microcap Index at the conclusion of the 2022 Russell indexes annual reconstitution, effective after the US market opens on June 27, 2002.

Key Points: 
  • NEW YORK, June 21, 2022 (GLOBE NEWSWIRE) -- Better Choice Company Inc. (NYSE: BTTR) (the Company or Better Choice), a pet health and wellness company, today announced that the Company is anticipated to join the Russell Microcap Index at the conclusion of the 2022 Russell indexes annual reconstitution, effective after the US market opens on June 27, 2002.
  • Membership in the Russell Microcap Index, which remains in place for one year, includes inclusion in the appropriate growth and value style indexes.
  • FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings, and style attributes.
  • For more information on the Russell Microcap Index and the Russell indexes reconstitution, go to the Russell Reconstitution section on the FTSE Russell website .

Healthy Extracts New Clinical Study Highlights UBN RELIEF Naturally Alleviates Migraine Symptoms

Retrieved on: 
Wednesday, June 8, 2022
OTCQB, Company, Doctor of Philosophy, Quality, Ultimate Brain, Recreation, Sale, Brain, Memory, MCT, Rehabilitation, Research, Ketone, Children's Hospital Colorado, Forward-looking statement, American College, Coffee, University of Colorado School of Medicine, Flavonoid, Quality of life, Polyphenol, Heart, UBN, Cognition, IP, Caffeine, Annual report, QOL, Government, University, Employment, BrainScope Company, Inc., Western Colorado Center for the Arts, Poster, SEC, Attention, Cognitive behavioral therapy for insomnia, Headache, Education, Private Securities Litigation Reform Act, Biomedical Advanced Research and Development Authority, Achievement, Health care, News, Disease, FDA, GLOBE, Risk, Water, Sport, CAGR, Person, Dietary supplement, Pharmaceutical industry, Fine chemical, Health, Migraine

The posterhighlights the improvement in quality of life (QOL) of migraineurs after consuming Healthy Extracts migraine headache formulation, UBN RELIEF .

Key Points: 
  • The posterhighlights the improvement in quality of life (QOL) of migraineurs after consuming Healthy Extracts migraine headache formulation, UBN RELIEF .
  • The study concluded that Healthy Extracts RELIEF, a medium chain triglyceride-based nootropic formulation, provided significant reductions in number and duration of migraine episodes for chronic migraine sufferers.
  • The study further builds upon Healthy Extracts recently reported results from a prospective, randomized, double-blind, placebo-controlled clinical trial that evaluated UBN RELIEF.
  • UBN RELIEF is based on a specialized version of a Healthy Extracts proprietary, patent-protected formulation.

BrainScope Named “Best New Diagnostic Technology Solution” in 2022 MedTech Breakthrough Awards Program

Retrieved on: 
Wednesday, May 11, 2022
Technology, Biotechnology, FDA, Health, Other Science, Other Technology, Research, Medical Devices, General Health, Science, Security, Clinical Trials, Nursing, Medical Supplies, Patient engagement in Canada, Head, EHR, Standard of care, American College, Global health, Brain, Fitness, Health, Intracranial hemorrhage, Algorithm, ACEP, Genomic and Medical Data, Concussion, ISO13485, Physician, Radiation, Injury, Attending physician, Triage, MDSAP, CT scan, BrainScope Company, Inc., Patient, Head injury, Exercise, Program, CT, FDA, Diagnosis, Artificial intelligence, Leadership, MHealth, Telehealth, Medtech, Medical device, Electronic health record, Health Canada, Technology, Brain damage, Sport, Fellow of the American College of Emergency Physicians, Medical imaging

Brain-assessment device innovator BrainScope , today announced that it has been selected as Best New Diagnostic Technology Solution in the sixth annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough , an independent market intelligence organization that recognizes the top companies, technologies and products in the global health and medical technology markets.

Key Points: 
  • Brain-assessment device innovator BrainScope , today announced that it has been selected as Best New Diagnostic Technology Solution in the sixth annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough , an independent market intelligence organization that recognizes the top companies, technologies and products in the global health and medical technology markets.
  • What an honor it is to receive this award from MedTech Breakthrough.
  • It is truly point-of-care and takes just minutes from patient preparation to results a true breakthrough that we are thrilled to recognize in our sixth annual MedTech Breakthrough Awards program.
  • Part of Tech Breakthrough , a leading market intelligence and recognition platform for global technology innovation and leadership, the MedTech Breakthrough Awards program is devoted to honoring excellence in medical and health related technology companies, products, services and people.

MedTech Breakthrough Honors Standout Digital Health and Medical Technology Innovation in 2022 MedTech Breakthrough Awards Program

Retrieved on: 
Thursday, May 5, 2022
Online, Cloud, EHR, MDR, Drug development, Digital health, Administration, Cardiology, MHealth, Face, Telehealth, Health information exchange, Solution, Technology, Genomic and Medical Data, Deepak Chopra, Ophthalmology, Dermatology, BrainScope Company, Inc., Honeywell, Program, Medtech, Medical device, National Healthcare Security Administration, Radiology, ECLIPSE, HIE, HC, GRAIL, Orthopedic surgery, Leadership, 3D, Patient engagement in Canada, Global health, Fitness, RICOH, Exercise, LexisNexis Risk Solutions, Schedule, Artificial intelligence, Health, Electronic health record, Pharmaceutical industry, Hospital, Medicine, Health insurance, Risk management, Medical imaging, Health care

LOS ANGELES, May 5, 2022 /PRNewswire-PRWeb/ -- MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global health and medical technology market, today announced the winners of the organization's sixth annual awards program, showcasing technologies and companies that drive innovation and exemplify the best in digital health and medical technology solutions across the globe.

Key Points: 
  • LOS ANGELES, May 5, 2022 /PRNewswire-PRWeb/ -- MedTech Breakthrough , an independent market intelligence organization that recognizes the top companies, technologies and products in the global health and medical technology market, today announced the winners of the organization's sixth annual awards program, showcasing technologies and companies that drive innovation and exemplify the best in digital health and medical technology solutions across the globe.
  • The mission of the MedTech Breakthrough Awards is to honor excellence and recognize the innovation, hard work and success in a range of health and medical technology categories, including Telehealth, Clinical Administration, Patient Engagement, Electronic Health Records (EHR), Connected Healthcare, Medical Devices, Medical Data and many more.
  • This year's program attracted more than 3,900 nominations from over 15 different countries throughout the world.
  • The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough health and medical companies and products in categories that include Patient Engagement, mHealth, Health & Fitness, Clinical Administration, Healthcare IoT, Medical Data, Healthcare Cybersecurity and more.

Prominent Emergency Medicine Expert Diku Mandavia, MD Joins BrainScope as Chief Medical Officer

Retrieved on: 
Tuesday, May 3, 2022
Health, Medical Devices, Other Health, Head, Partnership, Business, Portable ultrasound, Royal college, American College, Brain, American Board of Emergency Medicine, American Board of Commissioners for Foreign Missions, Emergency medicine, Health, ACEP, Algorithm, Concussion, Medical Center, Physician, Injury, Radiation, Attending physician, BrainScope Company, Inc., Patient, Anesthesia, Head injury, CT, FDA, ICU, Artificial intelligence, Diku, Innovation, Surgeon, MD, Publication, EDS, EEG, CTS, CMO, Memorial University of Newfoundland, Critical care, Solution, Technology, LAC+USC Medical Center, Stanford Graduate School of Business, Fellow of the American College of Emergency Physicians, ED, Medical device, Medical imaging

Brain injury-assessment device innovator BrainScope announced today that Diku Mandavia, MD, has joined the company as Chief Medical Officer.

Key Points: 
  • Brain injury-assessment device innovator BrainScope announced today that Diku Mandavia, MD, has joined the company as Chief Medical Officer.
  • With 28 years of emergency medicine experience and 15 years of commercial medical device experience, Dr. Mandavia is an expert in the importance of point-of-care triage in emergency medicine.
  • She added, Head injuries are at near epidemic levels with 4.8 million patients seeking care at Americas emergency rooms each year.
  • Previously, Dr. Mandavia served as the global Chief Medical Officer of FUJIFILM Sonosite Inc. since 2009 and FUJIFILM Medical USA since 2015.

Innovative MedTech Partners with TruCash Group of Companies to Launch A Health Care Payment Platform

Retrieved on: 
Friday, April 1, 2022
Company, Private Securities Litigation Reform Act, Exercise, BrainScope Company, Inc., Innovation, Adult, IMTH, Apple, Nursing, Hospital, BLUE, IOS, Health, Industry, Intention, Vitality, Medtech, GLOBE, Solution, OTC, Patient, Senior, Cryptocurrency, Online shopping, Visa

TruCash has more than 30 years of experience in providing payments, loyalty and financial solutions.

Key Points: 
  • TruCash has more than 30 years of experience in providing payments, loyalty and financial solutions.
  • TruCash has over 30 years experience in the financial services industry and is a highly recognized and proven leader in digital payments and loyalty concepts worldwide.
  • We plan to co-develop and launch a seamless heath minded app that allows for all these conveniences.
  • SarahCare offers seniors daytime care and activities ranging from exercise and medical needs daily to nursing care and salon services.

Joseph M. Kaye Named Partner at The Moskowitz Law Firm

Retrieved on: 
Tuesday, March 15, 2022
Insurance, University, University of Miami School of Law, Company, Plaintiff, Multimedia, LLC, Ethics, BrainScope Company, Inc., Family, Supreme Court of Florida, Aequorin, Certification, Florida Power & Light, View, Spartan Race, Tobacco, Property management, Partner

MIAMI, March 14, 2022 /PRNewswire/ -- The Moskowitz Law Firm is proud to announce Joseph M. Kaye has been promoted to Partner .

Key Points: 
  • MIAMI, March 14, 2022 /PRNewswire/ -- The Moskowitz Law Firm is proud to announce Joseph M. Kaye has been promoted to Partner .
  • Founding and Managing Partner Adam Moskowitz says:
    "We are honored and that Joey has accepted our offer to be a Partner in The Moskowitz Law Firm.
  • Since its founding in 2018, The Moskowitz Law Firm has quickly grown to become one of the preeminent Plaintiffs' Class Action law firms.
  • The Firm has resolved some of the largest class actions nationwide, co-counseling with dozens of plaintiffs' firms in their quests for justice.

Healthy Extracts New Clinical Study Demonstrates UBN RELIEF Naturally Alleviates Migraine Symptoms

Retrieved on: 
Tuesday, February 15, 2022
University of Colorado School of Medicine, Memory, Migraine, Cognition, Trust, Quality of life, Recreation, Water, Children's Hospital Colorado, BrainScope Company, Inc., Company, Government, Â, UBN, Coffee, Education, OTCQB, SEC, Brain, Ketone, Achievement, American College, Forward-looking statement, Private Securities Litigation Reform Act, Caffeine, IP, Polyphenol, Cognitive behavioral therapy, Annual report, GLOBE, Risk, Biomedical Advanced Research and Development Authority, Health care, MCT, Pharmacy, FDA, Sale, Headache, Flavonoid, Person, Employment, Sport, Disease, Ultimate Brain, Research, University, News, CAGR, Attention, Heart, Pharmaceutical industry, Dietary supplement, Fine chemical, Health

Moreover, the conclusions of the study reveal that UBN RELIEF can be a natural alternative for the tens of millions of migraine sufferers.

Key Points: 
  • Moreover, the conclusions of the study reveal that UBN RELIEF can be a natural alternative for the tens of millions of migraine sufferers.
  • It is important to note that these positive results from UBN RELIEF were achieved without producing any adverse side effects, stated Healthy Extracts president, Duke Pitts.
  • UBN RELIEF is based on a specialized version of a Healthy Extracts proprietary, patent-protected formulation.
  • UBN RELIEF is based on a specialized version of a Healthy Extracts proprietary, patent-protected formulation.